[Use of autologous serum in ophthalmic practice].

OBJECTIVE To establish a protocol for the use of autologous serum in the ophthalmic practice. METHODS Personal experience and a literature review. RESULTS The use of autologous serum, in eye drop form, has been reported as a new treatment for several ocular surfaces diseases. These products have biomechanical and biochemical properties similar to normal tears. They contain components such as fibronectin, vitamin A and growth factors that have an epitheliotrophic effect on the ocular surface epithelial cells. CONCLUSIONS The clinical studies performed showed a variable efficacy, with the preparative process and use of the autologous serum eye drops varying considerably between different studies.

[1]  S. Sawaguchi,et al.  REMOVAL OF RETINAL INDOCYANINE GREEN DYE BY AUTOLOGOUS SERUM IRRIGATION IN MACULAR HOLE SURGERY , 2005, Retina.

[2]  T. Wedel,et al.  An optimised protocol for the production of autologous serum eyedrops , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[3]  J. Blasco,et al.  Tratamiento de defectos epiteliales persistentes mediante suero autólogo , 2004 .

[4]  G. Geerling,et al.  Autologous serum eye drops for ocular surface disorders , 2004, British Journal of Ophthalmology.

[5]  B. Seitz,et al.  [Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects]. , 2004, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[6]  K. Tsubota,et al.  Autologous serum application in the treatment of neurotrophic keratopathy. , 2004, Ophthalmology.

[7]  D. Lam,et al.  The use of autologous serum tears in persistent corneal epithelial defects , 2004, Eye.

[8]  K. Pesudovs,et al.  Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease , 2004, British Journal of Ophthalmology.

[9]  H. Dua,et al.  A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders , 2004, British Journal of Ophthalmology.

[10]  R. Pandey,et al.  Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects , 2003, The British journal of ophthalmology.

[11]  K. Tsubota,et al.  Albumin as a tear supplement in the treatment of severe dry eye , 2003, The British journal of ophthalmology.

[12]  K. Tsubota,et al.  Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease , 2003, Bone Marrow Transplantation.

[13]  D. Díaz-Valle,et al.  Manejo de la queratopatía neurotrófica mediante tarsorrafia con cianocrilato y suero autólogo , 2003 .

[14]  C. Creuzot-Garcher,et al.  Treatment of Persistent Corneal Epithelial Defects by Autologous Serum , 2002 .

[15]  J. M. D. del Castillo,et al.  Treatment of Recurrent Corneal Erosions Using Autologous Serum , 2002, Cornea.

[16]  K. Tsubota,et al.  Treatment of Superior Limbic Keratoconjunctivitis by Application of Autologous Serum , 2001, Cornea.

[17]  H. Taylor,et al.  Controlled Study of the Use of Autologous Serum in Dry Eye Patients , 2001, Cornea.

[18]  J. Daniels,et al.  Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies , 2001, The British journal of ophthalmology.

[19]  S. Ebner,et al.  Glial cell-derived neurotrophic factor (GDNF)-induced migration and signal transduction in corneal epithelial cells. , 2001, Investigative ophthalmology & visual science.

[20]  P. Khaw,et al.  Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. , 2001, Investigative ophthalmology & visual science.

[21]  R. Ralph Tetracyclines and the Treatment of Corneal Stromal Ulceration: A Review , 2000, Cornea.

[22]  A. Vigorito,et al.  GVHD dry eyes treated with autologous serum tears , 2000, Bone Marrow Transplantation.

[23]  J. Eberle,et al.  HIV-1 infection transmitted by serum droplets into the eye: a case report. , 2000, AIDS.

[24]  K. Tsubota,et al.  Treatment of persistent corneal epithelial defect by autologous serum application. , 1999, Ophthalmology.

[25]  L. Laroche,et al.  Influence of fetal calf serum, fibroblast growth factors, and hepatocyte growth factor on three-dimensional cultures of human keratocytes in collagen gel matrix , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.

[26]  S. Wilson,et al.  Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding. , 1999, Investigative ophthalmology & visual science.

[27]  A. Panda,et al.  Lateral tarsorrhaphy: is it preferable to patching? , 1999, Cornea.

[28]  H. Dua,et al.  Amniotic membrane transplantation for ocular surface reconstruction , 1999, The British journal of ophthalmology.

[29]  S. Shivaji,et al.  Effect of storage on protein concentration of tear samples. , 1998, Current eye research.

[30]  K. Tsubota,et al.  Treatment of dry eye by autologous serum application in Sjögren’s syndrome , 1998, The British journal of ophthalmology.

[31]  K. Tsubota,et al.  Important concepts for treating ocular surface and tear disorders. , 1997, American journal of ophthalmology.

[32]  S. Kinoshita,et al.  Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye , 1997, The British journal of ophthalmology.

[33]  Michele De Luca,et al.  Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium , 1997, The Lancet.

[34]  R. Lavker,et al.  EGF-R dependent regulation of keratinocyte survival. , 1997, Journal of cell science.

[35]  C. Murphy,et al.  Synergistic effects of substance P with insulin‐like growth factor‐1 on epithelial migration of the cornea , 1996, Journal of cellular physiology.

[36]  K. Tsubota,et al.  Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. , 1996, American journal of ophthalmology.

[37]  S. Pflugfelder,et al.  Production and secretion of transforming growth factor beta (TGF-beta) by the human lacrimal gland. , 1996, Current eye research.

[38]  W. Mieler,et al.  Human autologous serum for the treatment of full-thickness macular holes. A preliminary study. , 1995, Ophthalmology.

[39]  D. Musch,et al.  Topical fibronectin ophthalmic solution in the treatment of persistent defects of the corneal epithelium. Chiron Vision Fibronectin Study Group. , 1995, American journal of ophthalmology.

[40]  C. Barnstable,et al.  Treatment of retinal breaks with autologous serum in an experimental model. , 1995, Ophthalmology.

[41]  C. Wardrop,et al.  Guidelines for administration of blood products: transfusion of infants and neonates , 1994 .

[42]  M. Nieto,et al.  Growth factors as survival factors: Regulation of apoptosis , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[43]  S. Tseng,et al.  Serum differentially modulates the clonal growth and differentiation of cultured limbal and corneal epithelium. , 1993, Investigative ophthalmology & visual science.

[44]  X M Wang,et al.  A new microcellular cytotoxicity test based on calcein AM release. , 1993, Human immunology.

[45]  J. F. Gordon,et al.  Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group. , 1992, American journal of ophthalmology.

[46]  J. Pastor,et al.  Epidermal Growth Factor and Corneal Wound Healing: A Multicenter Study , 1992, Cornea.

[47]  M. Göbbels,et al.  Corneal epithelial permeability of dry eyes before and after treatment with artificial tears. , 1992, Ophthalmology.

[48]  R. Pfister CLINICAL MEASURES TO PROMOTE CORNEAL EPITHELIAL HEALING , 1992, Acta ophthalmologica. Supplement.

[49]  Timo Tervo,et al.  EPIDERMAL GROWTH FACTOR (EGF) IN OCULAR FLUIDS: PRESENCE, ORIGIN AND THERAPEUTICAL CONSIDERATIONS , 1992, Acta ophthalmologica. Supplement.

[50]  S. Wilson,et al.  Basic fibroblast growth factor (FGFb) and epidermal growth factor (EGF) receptor messenger RNA production in human lacrimal gland. , 1991, Investigative ophthalmology & visual science.

[51]  T. M. Phan,et al.  Topical fibronectin in an alkali burn model of corneal ulceration in rabbits. , 1991, Archives of ophthalmology.

[52]  S. E. Kirschner,et al.  Persistent corneal ulcers. What to do when ulcers won't heal. , 1990, The Veterinary clinics of North America. Small animal practice.

[53]  S Kinoshita,et al.  Presence of epidermal growth factor in human tears. , 1989, Investigative ophthalmology & visual science.

[54]  P. McDonnell,et al.  Immunoglobulin deposition in the cornea after application of autologous serum. , 1988, Archives of ophthalmology.

[55]  J. Belmont,et al.  Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. , 1984, Arthritis and rheumatism.

[56]  T. Awata,et al.  Fibronectin. A new therapy for corneal trophic ulcer. , 1983, Archives of ophthalmology.

[57]  P. E. Dantas,et al.  [Effect of honey and autologous serum on corneal epithelial healing in rabbits]. , 2005, Arquivos brasileiros de oftalmologia.

[58]  M. Araie,et al.  Topical application of autologous serum for the treatment of late-onset aqueous oozing or point-leak through filtering bleb , 2005, Eye.

[59]  V. García Jiménez,et al.  [The elaboration, use and evaluation of eye-drops with autologous serum in corneal lesions]. , 2003, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

[60]  A. Cullinane,et al.  Effects of autologous platelet concentrate and serum on retinal wound healing in an animal model , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[61]  K. Barton,et al.  Cytokines and tear function in ocular surface disease. , 1998, Advances in experimental medicine and biology.

[62]  C. Meyer,et al.  [Transplantation of autologous submandibular glands in very severe keratoconjunctivitis sicca. 2 year outcome]. , 1998, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[63]  L. Ficker,et al.  Limbal transplantation. , 1996, Ophthalmology.

[64]  S. Pflugfelder,et al.  Transforming growth factor beta-1 and beta-2 in human tear fluid. , 1996, Current eye research.

[65]  W. Miller,et al.  First-order toxicity assays for eye irritation using cell lines: parameters that affect in vitro evaluation. , 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[66]  J. D. Nelson,et al.  Evaluation of a physiological tear substitute in patients with keratoconjunctivitis sicca. , 1994, Advances in experimental medicine and biology.

[67]  M. Nakamura,et al.  Effects of antimicrobials on corneal epithelial migration. , 1993, Current eye research.

[68]  C. Baudouin,et al.  Effects of aFGF and bFGF on wound healing in rabbit corneas. , 1987, Current eye research.

[69]  M. Insler,et al.  A comparison of therapeutic bandage lenses, tarsorrhaphy, and antibiotic and hypertonic saline on corneal epithelial wound healing. , 1986, Annals of ophthalmology.

[70]  N. Burstein The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye. , 1985, Transactions of the ophthalmological societies of the United Kingdom.